Page last updated: 2024-10-21

hydroxyindoleacetic acid and Carcinoma, Medullary

hydroxyindoleacetic acid has been researched along with Carcinoma, Medullary in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nobels, FR1
Kwekkeboom, DJ1
Coopmans, W1
Schoenmakers, CH1
Lindemans, J1
De Herder, WW1
Krenning, EP1
Bouillon, R1
Lamberts, SW1

Other Studies

1 other study available for hydroxyindoleacetic acid and Carcinoma, Medullary

ArticleYear
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:8

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Chromo

1997